SHPH
Income statement / Annual
Last year (2024), Shuttle Pharmaceuticals Holdings, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Shuttle Pharmaceuticals Holdings, Inc.'s net income was -$9.14 B.
See Shuttle Pharmaceuticals Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$6,811.00
|
$66,832.00
|
$60,834.00
|
$54,951.00
|
$18,000.00
|
$18,739.00
|
| Gross Profit |
$0.00
|
-$6,811.00
|
-$66,832.00
|
-$60,834.00
|
-$54,951.00
|
-$18,000.00
|
-$18,739.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$3.62 B
|
$3.52 M
|
$1.49 M
|
$1.02 M
|
$161,772.00
|
$55,572.00
|
-$836.00
|
| General & Administrative Expenses |
$1.39 B
|
$1.05 M
|
$1.07 M
|
$721,184.00
|
$347,750.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.39 B
|
$1.05 M
|
$1.07 M
|
$721,184.00
|
$347,750.00
|
$513,059.00
|
$185,987.00
|
| Other Expenses |
$2.68 B
|
$1.33 M
|
$328,687.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$7.70 B
|
$5.89 M
|
$2.55 M
|
$1.74 M
|
$509,522.00
|
$568,632.00
|
$185,151.00
|
| Cost And Expenses |
$0.00
|
$5.89 M
|
$2.55 M
|
$1.74 M
|
$509,522.00
|
$586,632.00
|
$203,890.00
|
| Interest Income |
$38.14 M
|
$79,117.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
-$8.69 M
|
$2.60 M
|
$969,889.00
|
$50,788.00
|
$39,630.00
|
$30,916.00
|
$10,881.00
|
| Depreciation & Amortization |
$0.00
|
$6,811.00
|
$5,972.00
|
$60,834.00
|
$54,951.00
|
$18,000.00
|
$18,739.00
|
| EBITDA |
-$7.70 B |
-$3.99 M |
-$4.32 M |
-$1.04 M |
-$711,151.00 |
-$577,223.00 |
-$183,971.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$1.45 B
|
-$700,343.00
|
-$474,170.00
|
$590,858.00
|
-$296,210.00
|
-$39,507.00
|
-$9,704.00
|
| Income Before Tax |
-$9.14 B
|
-$6.59 M
|
-$3.03 M
|
-$1.15 M
|
-$805,732.00
|
-$626,139.00
|
-$213,594.00
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$71,009.00
|
$50,788.00
|
$39,630.00
|
$0.00
|
$1.00
|
| Net Income |
-$9.14 B
|
-$6.59 M
|
-$3.10 M
|
-$1.20 M
|
-$845,362.00
|
-$626,139.00
|
-$213,594.00
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-3186.21 |
-0.41 |
-0.3 |
-0.0885 |
-0.0622 |
-0.0461 |
-0.0157 |
| EPS Diluted |
-3167.28 |
-0.41 |
-0.3 |
-0.0885 |
-0.0622 |
-0.0461 |
-0.0157 |
| Weighted Average Shares Out |
$2.87 M
|
$15.91 M
|
$10.35 M
|
$13.59 M
|
$13.59 M
|
$13.59 M
|
$13.59 M
|
| Weighted Average Shares Out Diluted |
$2.89 M
|
$15.91 M
|
$10.35 M
|
$13.59 M
|
$13.59 M
|
$13.59 M
|
$13.59 M
|
| Link |
|
|
|
|
|
|
|
